State Street Corp Lixte Biotechnology Holdings, Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.12 - $0.35 $54 - $159	456 Added 1.28%	35,956 $28,000
Q4 2021 Feb 14, 2022	BUY	$0.21 - $0.57 $399 - $1,083	1,900 Added 5.65%	35,500 $42,000
Q2 2021 Aug 16, 2021	BUY	$0.46 - $0.89 $15,456 - $29,904	33,600 New	33,600 $102,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.